(80 products available)
Ready to Ship
Ready to Ship
Growth factor receptors are the cell membrane receptors that are important signs of the corresponding growth factors. They play a critical role in cellular processes like proliferation, differentiation, and survival. The types include:
FGFRs are a family of four receptor tyrosine kinases that mediate the activity of fibroblast growth factors. These factors are responsible for biological processes like angiogenesis, wound healing, and bone formation.
It is a receptor that binds to epidermal growth factors. It is a receptor and tyrosine kinase. It regulates cell proliferation, differentiation, and survival. Mutations and dysregulations are associated with cancers and other diseases.
They are found in the family of receptor tyrosine kinases (RTKs). They bind to platelet-derived growth factors and are responsible for cell proliferation, chemotaxis, and cell migration. PDGFRα and PDGFRβ mediate these functions.
VEGFRs are a family of RTKs activated by a vascular endothelial growth factor. They are responsible for angiogenesis and vascular permeability and also play a role in lymphangiogenesis and tumor growth. They are important in treating edema.
IGF-1R is a transmembrane tyrosine kinase receptor that is activated by insulin and IGF-1. They are important for postnatal growth and development. They also influence cellular processes and metabolic regulation. Their dysregulation is associated with various forms of cancers and metabolic disorders.
Growth factor receptors are used to develop targeted therapies, including monoclonal antibodies and tyrosine kinase inhibitors. These treatments specifically inhibit or activate growth factor receptor pathways to prevent and treat diseases.
They are used in regenerative medicine, particularly in tissue engineering. Growth factors and their receptors are incorporated into biomaterial scaffolds or delivered in therapeutic cocktails to promote cell differentiation. This helps to stimulate tissue repair and regeneration in damaged areas, particularly in orthopedics, cardiovascular repair, and wound healing.
For example, antibodies targeting specific growth factors or receptors are used in immunohistochemistry and flow cytometry to detect receptor expression. This helps in tumor profiling to aid cancer staging. This helps to guide therapy decisions and predict patient outcomes in various diseases. The diseases include cancers, autoimmune disorders, and cardiovascular diseases.
The expression and activation of growth factor receptors can be utilized as biomarkers for disease progression. In cancer, for example, aberrations in receptor expression or signaling can indicate tumor aggressiveness. In this way, they help in early detection and monitoring therapeutic response.
Growth factor receptors are important in basic and applied research to understand cell biology. This helps to elucidate the mechanisms of disease pathogenesis. They are key research tools in studies related to cellular signaling, cancer biology, and developmental biology. This is due to their pivotal role in cell proliferation, differentiation, and survival.
They are also utilized in drug discovery processes where potential therapeutic agents targeting these receptors are developed.
In biomanufacturing, growth factors and their receptors are widely used in cell culture media. This helps to promote cell growth and tissue development. This is particularly important in producing biopharmaceuticals like monoclonal antibodies, vaccines, and cell-based therapies. Here, controlled cell growth and optimal differentiation are crucial for product yield and quality.
When selecting growth factor receptors, consider the following factors:
Determine the specific biological processes that need to be studied. Also, consider the cell type and species. For example, human vs. mouse vs. rat. Ensure the receptor of interest is relevant to the experimental model being used. This is because there are numerous growth factors and receptors.
Immunofluorescence and immunohistochemistry use antibodies to visualize receptor expression. These are often paired with growth factor receptor inhibitors or agonists to determine functional effects. Conversely, ELISA and western blot detect receptor activation by measuring phosphorylation.
Could the research involve a living cell? A living cell can be used to study ligand-receptor interactions, downstream signaling pathways, or cellular responses like proliferation and migration. This can be done using techniques like surface plasmon resonance or bioluminescence resonance energy transfer.
Utilize reagents with high specificity and sensitivity to avoid off-target effects. This is particularly important when studying closely related receptors like PDGFRα and PDGFRβ.
If the aim is to block or stimulate receptor activity, selecting the right agonists is critical. Check for available receptor inhibitors or agonists that are well-characterized for the target receptor.
Make sure they are validated in relevant cell types. Additionally, ensure they have been tested in cellular or animal models similar to the target research system. Consider the dosage range and effectiveness data. Check if there are published studies demonstrating their effectiveness, particularly for the receptor of interest.
For research, select growth factor receptors based on the experimental needs and what deliverable needs to be produced. In contrast, for clinical applications, choose receptors that meet regulatory requirements and standards for safety and efficacy.
Growth factor receptors can be maintained and repaired in a variety of ways. Maintenance is done by ensuring optimal conditions for receptor activation. This is achieved through the supply of their corresponding growth factors. These are often supplemented in cell cultures or delivered in vivo via gene therapy.
Receptor integrity can also be preserved through periodic analysis using techniques like flow cytometry. This enables constant monitoring of receptor expression and function. The role of ligand-receptor interaction is critical not just for activation but for maintaining receptor viability and preventing degradation. This is an essential part of the maintenance process.
On the other hand, damage to growth factor receptors can occur due to prolonged stress, oxidative damage, or pathological conditions. Various techniques can repair these damaged receptors, including:
Gene Therapy
This technique is primarily used in disorders like cystic fibrosis and certain kinds of muscular dystrophy. In these cases, damaged or mutated genes coding for dysfunctional receptors are delivered in vivo through viral vectors.
The delivered genes then produce functional receptors, which restore normal cell signaling. For example, IGF-1R gene therapy successfully repaired receptor functionality in muscle-wasting diseases by increasing muscle regeneration.
Small Molecule Modulators
These are designed to target specific types of antibodies that inhibit the activity of aberrant receptors. They bind to the damaged growth factor receptors to help restore their normal function. In some cancers with overactive EGFR pathways, small inhibitors are administered to dampen the receptor activity, allowing cells to normalize their growth.
Protein-Based Therapies
These work by delivering either engineered versions of ligands or receptor antagonists. They correct abnormal signaling. In diabetic patients, exogenous IGF-1 ligands are administered to activate the insulin-like pathway for glucose homeostasis.
Conversely, in hyperproliferative disorders, EGFR antagonists are delivered to block excessive cell division.
Antisense Oligonucleotides
These are designed to bind and inhibit mRNA transcripts of malfunctioning growth factor receptors. This is done to prevent the synthesis of defective proteins, which is a typical method in genetic disorders like familial hypocholesterolemia. In this case, ASOs targeting mutated LDL receptors protect the patients from early cardiovascular disease.
A1. Authenticity can be performed through multiple validations. These include receptor binding assays, where the ligand interaction with the receptor is measured using techniques like surface plasmon resonance.
Another technique is functional assays to evaluate the biological activity. This examines if the ligand-receptor complex is signaling properly. Receptor occupancy studies also help by demonstrating whether the ligands bind to the target receptor in living cells.
Finally, using highly specific antibodies that only bind to the target activated receptor can verify the receptor's identity.
A2. Yes, many growth factors come with vehicles. They are administered using various vehicles that enhance stability, control release, and improve targeting. These include liposomes, which are small vesicles that encapsulate growth factors for targeted delivery inside the cell. They enhance the stability of the growth factor and ensure it is released slowly and safely.
Microparticles are similar but larger, providing prolonged release and a reservoir of growth factors for extended therapeutic effects. Another common vehicle is hydrogels, which are three-dimensional polymer networks that can encapsulate growth factors while maintaining them for several days or weeks.
A3. Plants do not have human-like growth factor receptors since they are structurally and functionally different. However, some studies use plant model systems to understand fundamental aspects of these receptors. This is because while the receptors may not be identical, their essential signaling functions can sometimes be complemented by analogous plant proteins.
Therefore, while informative for certain basic biological principles, plant systems lack human-specific physiological context. This makes them less effective for studying human diseases or developing targeted therapies against growth factor receptors.
浙公网安备 33010002000092号
浙B2-20120091-4